Carson Wealth (CWM LLC)’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,190
| Closed | -$123K | – | 4658 |
|
|
2023
Q2 | $123K | Buy |
3,190
+2,010
| +170% | +$51.6K | ﹤0.01% | 1466 |
|
|
2023
Q1 | $27K | Hold |
1,180
| – | – | ﹤0.01% | 2307 |
|
|
2022
Q4 | $31K | Hold |
1,180
| – | – | ﹤0.01% | 2069 |
|
|
2022
Q3 | $23K | Hold |
1,180
| – | – | ﹤0.01% | 2154 |
|
|
2022
Q2 | $21K | Hold |
1,180
| – | – | ﹤0.01% | 2095 |
|
|
2022
Q1 | $19K | Hold |
1,180
| – | – | ﹤0.01% | 2124 |
|
|
2021
Q4 | $19K | Buy |
+1,180
| New | +$16.8K | ﹤0.01% | 2034 |
|
|
2021
Q2 | $17K | Hold |
1,180
| – | – | ﹤0.01% | 1883 |
|
|
2021
Q1 | $17K | Hold |
1,180
| – | – | ﹤0.01% | 1883 |
|
|
2020
Q4 | $17K | Buy |
1,180
+944
| +400% | +$14.2K | ﹤0.01% | 1882 |
|
|
2020
Q3 | $17K | Hold |
236
| – | – | ﹤0.01% | 1882 |
|
|
2020
Q2 | $17K | Hold |
236
| – | – | ﹤0.01% | 1882 |
|
|
2020
Q1 | $17K | Hold |
236
| – | – | ﹤0.01% | 1882 |
|
|
2019
Q4 | $17K | Hold |
236
| – | – | ﹤0.01% | 1881 |
|
|
2019
Q3 | $17K | Hold |
236
| – | – | ﹤0.01% | 1881 |
|
|
2019
Q2 | $17K | Hold |
236
| – | – | ﹤0.01% | 1881 |
|
|
2019
Q1 | $17K | Buy |
+236
| New | +$4.12K | ﹤0.01% | 1881 |
|
Carson Wealth (CWM LLC)'s KDNY Position: Q3 2023 in Review
Carson Wealth (CWM LLC) sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 3,190 shares — an estimated $123K sold.
Carson Wealth (CWM LLC) first reported a position in KDNY in Q1 2019 and held it in 17 quarters. The position peaked at $123K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Carson Wealth (CWM LLC) reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Carson Wealth (CWM LLC) sold 3,190 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $123K.
- Carson Wealth (CWM LLC) first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2019 and held it in 17 quarters.
- Carson Wealth (CWM LLC)'s Chinook Therapeutics, Inc. Common Stock position peaked at $123K in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q3 2023, filed 11 Oct 2023.